Language : English
Published : 2016
Pages : 851
Jawetz, Melnick & Adelberg’s Medical Microbiology
Out of stock
For one-semester Anatomy & Physiology courses. Focus on the essential what, how, & why of human anatomy & physiologyWith the 12th Edition of Essentials of Human Anatomy & Physiology, science educator Suzanne Keller joins bestselling author Elaine Marieb in helping learners focus on the essential What, How, & Why of A&P, without getting sidetracked in unnecessary details. Thoroughly updated with dozens of new figures, photos, and current information on medical recommendations and terminology, the 12th Edition continues to set the standard for brief, accessible one-semester A&P texts. The authors’ hallmark clear and friendly writing style has been strengthened with familiar analogies and abundant mnemonic cues that help students learn and remember concepts. Continuing to offer just the right balance of anatomy, physiology, and clinical coverage, engaging new chapter previews help learners hone in on what structures and functions they are studying, how they function, and why they are important to learn. Mastering (TM) A&P not included. Students, if Mastering A&P is a recommended/mandatory component of the course, please ask your instructor for the correct ISBN and course ID. Mastering A&P should only be purchased when required by an instructor. Instructors, contact your Pearson rep for more information.Mastering A&P is an online homework, tutorial, and assessment program designed to engage students and improve results. Instructors ensure that students arrive ready to learn by assigning educationally effective content before class, and encourage critical thinking and retention with in-class resources such as Learning Catalytics (TM). Students can further master concepts after class through assignments that provide hints and answer-specific feedback. With a wide range of activities available, students can actively learn, understand, and retain even the most difficult concepts.
Evidence-Based Validation of Herbal Medicines brings together current thinking and practice in the areas of characterization and validation of natural products. This book reviews all aspects of evaluation and development of medicines from plant sources, including their cultivation, collection, phytochemical and phyto-pharmacological evaluation, and therapeutic potential. Emphasis is placed on describing the full range of evidence-based analytical and bio-analytical techniques used to characterize natural products, including -omic technologies, phyto-chemical analysis, hyphenated techniques, and many more. * Includes state-of-the-art methods for detecting, isolating, and performing structure elucidation by degradation and spectroscopic techniques* Covers biosynthesis, synthesis, and biological activity related to natural products* Consolidates information to save time and money in research* Increases confidence levels in quality and validity of natural products.
About the Author
Dr. Pulok K. Mukherjee, Director, School of Natural Product Studies, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India, has been working on traditional medicine inspired drug discovery leading to development of therapeutic leads from natural resources. His research work highlights screening, evaluation, formulation, and standardization of herbal drugs with their validation to ensure quality, safety, and efficacy. He has made innovative, outstanding, and original contributions both in education and research in the area of natural products. Dr. Mukherjee is a Fellow of the Royal Society of Chemistry (FRSC), UK. He completed his masters and PhD in pharmacy from Jadavpur University and post-doctoral research from Leiden/Amsterdam Center for Drug Research, The Netherlands. His research career has been outstanding, including globally-acclaimed contributions on evaluation of the holistic medicine as useful bio-prospecting tools for the traditional medicine based drug discovery program so as to make them available from “Farm to Pharma . His work has led to many important national and international projects in the field of Natural Health Products. He has worked on leveraging innovations in traditional Indian medicine, particularly on rationally designed, carefully standardized, synergistic traditional herbal formulations and botanical drugs for their scientific validation on evidence based approaches. His efforts on development of integrated approaches for drug development from Indian traditional medicine have worldwide impact for the promotion of traditional medicine inspired drug discovery. Based on these works, he has to his credit more than 174 publications in peer reviewed impact journals, several patents and 20 books/book chapters on various aspects of herbal medicine. His research publications have a cumulative Impact Factor of 186.43. Google Citations database indicates that his works have h-Index- 41, i10-index- 126; which has been cited over 7630 times. He has worked as visiting scientist in several renowned universities abroad including The School of Pharmacy, University of London; King’s College London; Leiden/Amsterdam Center for Drug Research, Netherlands; School of Health Science, Tokushima University, Japan; Medical Research Council, Cape Town, South Africa. He has developed several products, and processes with partnership between industry and institutes. He has been awarded with many laurels from the Government of India and abroad; to name a few: the prestigious Commonwealth Academic Staff Fellowship from the Association of Commonwealth Universities (ACU), UK; Outstanding Service Award from the Drug Information Association (DIA), USA; Career Award for Young Teachers from the All India Council for Technical Education (AICTE), Government of India; Overseas Award from the Department of Biotechnology (DBT), BOYSCAST Fellowship from Department of Science & Technology (DST), Government of India; Young Pharmacy Teacher Award from the Association of Pharmaceutical Teachers of India; and the IPA Fellowship Award from the Indian Pharmaceutical Association (IPA). Dr. Mukherjee is working on the dissemination of knowledge on promotion and development of natural products with international coordination and collaboration on globalizing local knowledge and localizing global technologies in the area of traditional medicine. He has delivered over 200 lectures at different international and national podiums on leveraging innovations in traditional Indian medicine particularly on its validation for the safety, quality, and efficacy with the evidence based scientific claims. He has organized 16 potential national and international conferences, workshops, and seminars with the involvement of scientists all over the world. He is actively involved with several professional organizations. He is Member of the board on International Society for Ethnopharmacology, UK; Secretary of the Society for Ethnopharmacology (SFE), India; Council member of the Society for TCM Pharmaceutical Analysis, China; and others. Dr. Mukherjee is serving as Associate Editor of the Journal of Ethnopharmacology, Elsevier Science. He is the member of the editorial board of ten other Indian and international journals. He is also associated as advisor to different organizations and administrative bodies of the Government of India and abroad.
This significantly expanded and newest edition of the bestselling HIMSS Dictionary of Health Information Technology Terms, Acronyms, and Organizations has been developed and extensively reviewed by more than 50 industry experts. The fourth edition of this dictionary serves as a quick reference for students, health information technology professionals and healthcare executives to better navigate the ever-growing health IT field. This valuable resource includes more than 3000 definitions, 30 new organizations and 76 new references. Definitions of terms for the information technology and clinical, medical and nursing informatics fields are updated and included. This fourth edition also includes an acronyms list with cross references to current definitions, new word-search capability (e-book version only), and a list of health IT-related associations and organizations, including contact information, mission statements and web addresses. Academic and certification credentials are also included. HIMSS North America, a business unit within HIMSS, positively transforms health and healthcare through the best use of information technology in the United States and Canada. As a cause-based non-profit, HIMSS North America provides thought leadership, community building, professional development, public policy, and events. HIMSS North America represents 64,000 individual members, 640 corporate members, and over 450 non-profit organizations. Thousands of volunteers work with HIMSS to improve the quality, cost-effectiveness, access, and value of healthcare through IT. HIMSS Vision Better health through information technology. HIMSS Mission Globally, lead endeavors optimizing health engagements and care outcomes through information technology.
About the Author
HIMSS is a global voice, advisor and thought leader of health transformation through Health IT with a unique breadth and depth of expertise and capabilities to improve the quality, safety, and efficiency of health, healthcare and care outcomes. As the leading source of Health IT, HIMSS designs and leverages key data assets, predictive models and tools to advise global leaders, stakeholders and influencers of best practices in Health IT so they have the right information at the point of decision. Through its HIT network of over 1 million experts, over 200 knowledge exchanges and collaborations, including 60,000 plus members, HIMSS drives innovative; forward thinking around best uses of technology in support of better connected care, improved population health and low cost of care. HIMSS is a not for profit, headquartered in Chicago, Illinois with additional offices in North America, Latin America, Europe, United Kingdom and Asia.
New and emerging directions in pharmaceutical research to better treat schizophrenia
Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease. Moreover, many schizophrenia patients fail to respond to current antipsychotics. Integrating chemistry, biology, and pharmacology, this book explores emerging directions in pharmaceutical research for drug targeting and discovery in order to find more effective treatments for schizophrenia, one of the most serious and widespread psychiatric diseases.
Targets and Emerging Therapies for Schizophrenia presents the basics of schizophrenia, drug targets for the disease, and potential new drugs and therapeutics. It begins with a discussion of prevalence and etiology. Then, it describes therapies such as dopamine agonists and phosphodiesterase (PDE) inhibitors as well as growing research aimed at addressing untreated symptoms. Next, the authors discuss receptor modulators, inhibitors, and targeting strategies for drug discovery. Both the neurobiological and chemical aspects of all major pharmacological targets are examined.
With contributions from an international team of pioneering pharmaceutical researchers, this book compiles the current knowledge in the field, setting the stage for new breakthroughs in the treatment of schizophrenia. Targets and Emerging Therapies for Schizophrenia:
- Provides a comprehensive resource for neuro-drug discovery and the development of molecular targets for schizophrenia treatment
- Draws from chemistry, biology, and pharmacology for more effective drug targeting and discovery
- Explores a wide range of receptors and molecular targets, including dopamine, PDEs, and neuropeptides
With Targets and Emerging Therapies for Schizophrenia as their guide, drug discovery and development scientists have the information they need to advance their own research so that new, more effective treatments for schizophrenia will soon be a reality.